Practice guidelines and clinical risk assessment models: is it time to reform? by unknown
DEBATE Open Access
Practice guidelines and clinical risk assessment
models: is it time to reform?
Nariman Sepehrvand1*, Firouz Ghaderi Pakdel2, Mohammad Hosein Rahimi-Rad3, Babak Moosavi-Toomatari1 and
Shahrzad Bazargan-Hejazi4
Abstract
Background: Clinical practice guidelines and Risk Assessment Models (RAMs) are some useful tools to bring
medical evidences into our daily clinical practice. Despite the improvement over the time, they still have some
shortcomings.
Discussion: One of these shortcomings is the arbitrary cutoffs used in these tools to facilitate the decision making
process. This problem is to some extent due to the “Black or White” approach of modern medicine in making the
decisions, whilst in the real world and our daily practice we used mostly an uncertain approach, which is called
recently as “Fuzzy” thinking approach.
Summary: The authors of this article believe that the fuzzy type of thinking may resolve the above mentioned
shortcomings of clinical practice guideline or risk assessment models and they tried to discuss about this using an
example about Venous Thromboembolism related guidelines and RAMs.
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Background
Clinical practice guidelines are useful decision support
tools in the process of carrying medical evidences to the
point of practice [1]. An example for an important
health system problem which experiences a gap between
medical evidences and clinical practice is venous throm-
boembolism (VTE) [2].
Several practice guidelines have developed and focused
on this topic, among which the most important one is
the evidence-based VTE prevention practice guideline
generated and updated by the American College of
Chest Physicians (ACCP) [3]. This guideline proposes
clinical decision making regarding identification and
screening of thromboprophylaxis according to the pre-
sence of risk factors in various patient groups. This
method of risk evaluation, underestimates the risk of
venous thromboembolism in some cases [4]. However
this guideline in a section mentioned the individual
patient risk assessment and advocates for the use of
clinical judgment in some specific circumstances [3].
Despite development of various Practice guidelines for
prevention of Venous Thromboembolism (VTE), it
remains underused in most countries [5,6]. Improving
clinician’s compliance with the guidelines is a complex
task and partly rest on improving thrombotic risk-
assessment methods [7]. There are several risk assess-
ment tools for VTE prevention, from which the three
most notable models were developed by Caprini, Cohen,
and Kucher [4,8,9]. These models considered the indivi-
dualized approach to the VTE risk determination in
each patient [3]. These risk assessment models (RAM)
consist of a list of exposing risk factors (presenting ill-
ness or procedure) and predisposing risk factors (genetic
and clinical characteristics), each with an assigned rela-
tive risk score [4,10]. As stated in the 8th annual confer-
ence of ACCP and the earlier editions of the ACCP
guideline, the VTE risk factors are generally cumulative
[3,11]. In another words, scores for each risk factor are
summed to produce a cumulative score, and is used to
classify a patient into one of the four risk categories and
determine the onset, intensity, type, and duration of
recommended prophylaxis [12].
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The 8th ACCP conference on VTE prevention, allo-
cated a section to the aforementioned risk assessment
models [3] criticizing these models for being cumber-
some, and not validated adequately. On the other hand
several studies in the past few years have validated the
Caprini risk assessment model and linked the score to
the eventual development of clinically relevant VTE
events up to 60 days post discharge [13-15]. While the
original model put people in 4 groups, the validation
studies have shown that for each increase in score, the
incidence of VTE rises [13]. At the same time, the
important role of these models in developing a compu-
terized decision making support systems for clinicians
was discussed. Clinical informatics and electronic health
records have the potential to ease application of risk
assessment model [7].
Another major critique pointed out by the later edi-
tion of ACCP guideline regarding the risk assessment
models, is the arbitrary cutoffs for age and duration of
surgery [3]. We are aimed in this article to suggest a
way to address this critique of ACCP guideline to
RAMs.
Discussion
We (the authors) do not confine this shortcoming of
RAMs (i.e arbitrary cutoffs) only to age or the duration
of surgery as noted by the ACCP guideline. Many other
risk factors such as Body Mass Index (BMI), history of
major surgery, Stroke, multiple trauma, hip, pelvic and
leg fractures in one month prior to hospitalization may
have such problem in determining the total VTE risk of
an individual.
An example may clarify the issue: a 61 years old man
with a history of major surgery of cholecystectomy in
the past year is admitted to your hospital with a pro-
gressive stroke. Also, another patient, a 74 years old
woman with a history of Coronary Artery Bypass Graft
(CABG) in the past year, is admitted with a mild Transi-
ent Ischemic Attack (TIA). The point score for both two
patients using the Caprini Risk Assessment model is 8
and includes 1 for the history of major surgery, 2 for
age, and 5 for stroke during the month prior to hospita-
lization for the first patient, and 2 for age, 4 for history
of CABG, and at least 2 for admission with TIA for the
second one. The patients acquired equal scores for their
ages, but are 61 and 74 years old equal in predisposing
VTE? According to the Caprini model, patients between
41-60 years old are assigned one score, and patients
between 61-74 years old are assigned 2 score for VTE
risk [4]. What is the real difference between 59 and 61
years old, which 1 was assigned for one of them and 2
was assigned for the other? This problem is due to men-
tioned arbitrary cutoff points which were addressed in
the 8th ACCP practice guideline too. How were these
cutoff points determined? The cutoff points for age,
length of surgery, and BMI were determined over the
past 25 years and have solid bases in the literature
[11,16]. Also several studies have validated these data
(cutoff points which were applied in risk assessment
models) and confirmed the use of them to predict the
60 day clinically relevant VTE event [13-15].
Cutoff points are the corner stones and also the flaw
of medical guidelines (even evidence-based guidelines).
A patient with a body temperature more than 37.2°C
axillary in the morning is considered as febrile, but is
there a significant difference between 37.1 and 37.3°C,
to consider one as febrile and the other one as afebrile?
The complex mind of the human does not work like
this (with a binary pattern) during its daily interpreta-
tions or decision makings.
The authors of this article believe that, this problem of
risk assessment models (i.e. arbitrary cutoffs) can be
corrected using fuzzy logic in decision making process.
Fuzzy logic which was first introduced by Lotfi A.
Zadeh in 1965, transcends the “black and white”
approach of the Aristotelian logic, and tries to capture
the wide grey areas of imprecision in between [17]. This
logic provides a mathematical approach to interpret the
grey zones of imprecision.
Considering the imprecise nature of the individual’s
personal and physical characteristics, Lotfi A. Zadeh
anticipated that medicine probably would be the main
domain for the application of his theory [18]. But
despite this prominent forecast, its progression in the
field of medicine remained slow [19].
In recent years interesting proposals for the applica-
tion of fuzzy logic in medical sciences have been
appeared in the literature [20-22], and in this regard a
special mention has to be made to the contributions
coming from the group of Helgason, aiming for example
to better individualize diagnostic process [23], or pre-
scribing and dosing of particular medications at the bed-
side [24,25].
A new approach to medicine which has had a rapid
and continuing growth in the field is the practice of evi-
dence-based medicine (EBM) [26]. The ACCP guidelines
for VTE prophylaxis were provided by this evidence-
based approach. Some authors consider EBM and Fuzzy
logic as two sides of a same coin. The authors of this
article believe that fuzzy logic approach is not in con-
trast to the evidence-based medicine approach, but it is
a complementary tool for a more realistic approach to
the practice of evidence-based medicine. Fuzzy logic by
capturing the grey zone in medical decision makings
increases the reliability of risk assessment models. The
probabilistic approach of the Fuzzy logic amplifies the
applicability of electronic alerts and computerized deci-
sion-support systems.
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Medical guidelines and risk assessment models cap-
ture clinical findings (history or physical examination)
and para-clinical findings [12] in the process of deter-
mining medical decision. However, as was mentioned
above, most of these findings in reality cannot project a
binary (black or white) approach. Consider “Swollen
legs” in a physical exam: In fuzzy manner of thinking,
every body has “swollen legs” to some degree. This
degree of membership is almost zero for normal and
healthy people, and maybe near 1 for patients with 4+
pitting edema in legs.
ACCP guideline declared “there is little formal
understanding of how the various risk factors interact
in a quantitative manner to determine the position of
each patient along a continuous spectrum of throm-
boembolic risk”[3]. Indeed, this is a particular case of
fuzzy thinking model. In fuzzy manner of thinking, the
risk of VTE rest on a continuum. The input from risk
assessment models (or even practice guidelines) could
be fuzzified for variables that are compatible with this
way of thinking. In fuzzy logic, partial antecedents
result in partial implications. As a consequence, the
output of these risk assessment models will be a fuzzy
variable with a degree of membership in each of two
neighbor options. Then the outcome (output) of this
system could be defuzzified to identify which option is
more preferable.
By merging and concurrent use of these two
approaches (EBM and Fuzzy logic) in the process of
decision-making, fuzzy logic can yield its suitable place
in the field of medicine, considering the rapidly progres-
sion of evidence-based medicine in this field.
It seems that lack of adequate validity studies, limited
number of thromboprophylaxic options, or the complex-
ity of using these risk assessment models for physicians
is not enough to burying risk assessment models, and
advocating for the simple approach (risk of each patient
group) used by ACCP guideline. Fuzzy-based computer-
ized decision support systems can resolve most of the
ACCP guidelines shortcomings.
Patients with lower levels of VTE risk may be more
affected by using the fuzzy manner of thinking, because
among these patients, the application of fuzzy logic may
alter the risk level and the options of thromboprophy-
laxis due to change in cumulative risk score.
The total risk score of patients with higher risk levels
(risk score > 7 in Caprini model) may be decreased to
some extent using the fuzzy approach, but the option of
thromboprophylaxis is similar to when the fuzzy logic is
not applied.
As discussed above, a reform in the field of risk
assessment tools is needed to enhance their applicabil-
ities in accordance with the expectations of clinicians, as
the natural fuzzy thinking systems.
Summary
The application of Fuzzy thinking model in developing
decision support systems can resolve most of the short-
comings of risk assessment models and practice
guidelines.
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